USIBC urges govt to ease regulatory curbs on APIs, medical devices Medical Dialogues Bureau30 March 2020 2:58 PM ISTUS-India Business Council has written to Prime Minister Narendra Modi this week to suggested the Centre to "temporarily relax regulatory barriers that...
Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung Medical Dialogues Bureau30 March 2020 1:19 PM ISTZurich: Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's...
Sun Pharma: USFDA classifies Halol facility as Official Action Indicated Medical Dialogues Bureau30 March 2020 1:18 PM ISTMumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
Mylan, Lupin Announce Positive CHMP Opinion for Nepexto Medical Dialogues Bureau29 March 2020 1:32 PM ISTHertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 1:19 PM ISTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
Novartis, Life sciences companies commit to fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation Medical Dialogues Bureau29 March 2020 12:19 PM ISTBasel: Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture, and...
Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 12:15 PM ISTVenclexta/Venclyxto is being developed by AbbVie and Roche.
USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema Medical Dialogues Bureau29 March 2020 11:27 AM ISTAD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects
Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus Medical Dialogues Bureau28 March 2020 1:30 PM ISTHertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
Philips to ramp up production of ventilators in coronavirus fight Medical Dialogues Bureau28 March 2020 1:00 PM ISTAmsterdam: Dutch health technology company Philips is to ramp up production of critical healthcare products to help diagnose and treat patients with...
Prophylaxis effect of hydroxychloroquine in COVID-19: Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota research Medical Dialogues Bureau28 March 2020 12:52 PM ISTThe trial is being led by internationally recognized infectious disease expert David Boulware, MD, MPH and his research team among 1,500 healthcare...
With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19 Medical Dialogues Bureau28 March 2020 12:09 PM ISTAbbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID...
